Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Curis, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
CRIS
Nasdaq
2834
www.curis.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Curis, Inc.
How The Narrative Around Curis (CRIS) Is Shifting As Assumptions Change Not The US$14 Target
- Feb 10th, 2026 7:08 pm
Looking At The Narrative For Curis CRIS After Fresh Funding And Fair Value Reset
- Jan 11th, 2026 11:08 am
Curis Announces Closing of Private Placement Totaling up to $80.8 Million in Gross Proceeds
- Jan 9th, 2026 6:00 am
Curis Announces Pricing of Private Placement Totaling up to $80.8 Million in Gross Proceeds
- Jan 7th, 2026 6:45 am
Curis Provides Updated Data from its Frontline AML Triplet Study
- Dec 9th, 2025 6:00 am
How Recent Developments Are Shaping the Curis Investment Story
- Nov 28th, 2025 3:08 am
Curis to Present at Upcoming 30th Annual SNO Meeting
- Nov 14th, 2025 7:26 am
Why Analysts Are Rethinking Curis After Nasdaq Warning and Price Target Drop
- Nov 13th, 2025 5:17 am
Analysts Have Been Trimming Their Curis, Inc. (NASDAQ:CRIS) Price Target After Its Latest Report
- Nov 9th, 2025 6:50 am
Curis Inc (CRIS) Q3 2025 Earnings Call Highlights: Promising Study Results and Financial ...
- Nov 6th, 2025 10:02 pm
Curis (CRIS) Reports Q3 Loss, Beats Revenue Estimates
- Nov 6th, 2025 3:10 pm
Curis: Q3 Earnings Snapshot
- Nov 6th, 2025 2:08 pm
Curis Provides Third Quarter 2025 Business Update
- Nov 6th, 2025 2:00 pm
Curis to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on November 6, 2025
- Oct 30th, 2025 2:00 pm
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Oct 3rd, 2025 2:00 pm
Curis to Present at Upcoming Healthcare Conferences in September
- Sep 2nd, 2025 8:42 am
Curis Inc (CRIS) Q2 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
- Aug 6th, 2025 9:00 am
Curis (CRIS) Reports Q2 Loss, Beats Revenue Estimates
- Aug 5th, 2025 7:10 am
Curis: Q2 Earnings Snapshot
- Aug 5th, 2025 6:08 am
Curis Provides Second Quarter 2025 Business Update
- Aug 5th, 2025 6:00 am
Scroll